A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
Clinical trial NCT00545688 · COMPLETED
Trial details
- NCT number
- NCT00545688
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-26
- Primary completion
- 2014-09-22
- Enrollment
- 417
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.